ANIKA THERAPEUTICS INC (ANIK) Stock Price, Forecast & Analysis
NASDAQ:ANIK • US0352551081
ANIK Key Statistics, Chart & Performance
The current stock price of ANIK is 10.52 USD. In the past month the price increased by 11.21%. In the past year, price decreased by -39.51%.
ANIK Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to ANIK. When comparing the yearly performance of all stocks, ANIK is a bad performer in the overall market: 83.19% of all stocks are doing better.
ANIK Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ANIK. No worries on liquidiy or solvency for ANIK as it has an excellent financial health rating, but there are worries on the profitability.
ANIK Financial Highlights
Over the last trailing twelve months ANIK reported a non-GAAP Earnings per Share(EPS) of -2.28. The EPS increased by 53.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.44% | ||
| ROE | -22.5% | ||
| Debt/Equity | 0 |
ANIK Forecast & Estimates
8 analysts have analysed ANIK and the average price target is 16.32 USD. This implies a price increase of 55.13% is expected in the next year compared to the current price of 10.52.
For the next year, analysts expect an EPS growth of 46.29% and a revenue growth -26.08% for ANIK
ANIK Ownership
ANIK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.75 | 411.552B | ||
| AMGN | AMGEN INC | 16.85 | 201.047B | ||
| GILD | GILEAD SCIENCES INC | 17.12 | 192.64B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.07 | 121.106B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.05 | 83.892B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 49.66 | 43.941B | ||
| INSM | INSMED INC | N/A | 32.101B | ||
| NTRA | NATERA INC | N/A | 29.393B | ||
| BIIB | BIOGEN INC | 12.76 | 28.709B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.15 | 20.773B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ANIK
Company Profile
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. The company is headquartered in Bedford, Massachusetts and currently employs 288 full-time employees. The firm is leveraging its core expertise in hyaluronic acid and implant solutions. The company partners with clinicians to provide minimally invasive products that restore active living for people around the world. The company is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. The company is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
Company Info
ANIKA THERAPEUTICS INC
32 Wiggins Ave
Bedford MASSACHUSETTS 01730 US
CEO: Cheryl R. Blanchard
Employees: 288
Phone: 17814579000
ANIKA THERAPEUTICS INC / ANIK FAQ
What does ANIK do?
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. The company is headquartered in Bedford, Massachusetts and currently employs 288 full-time employees. The firm is leveraging its core expertise in hyaluronic acid and implant solutions. The company partners with clinicians to provide minimally invasive products that restore active living for people around the world. The company is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. The company is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
What is the stock price of ANIKA THERAPEUTICS INC today?
The current stock price of ANIK is 10.52 USD. The price increased by 0.96% in the last trading session.
What is the dividend status of ANIKA THERAPEUTICS INC?
ANIK does not pay a dividend.
What is the ChartMill technical and fundamental rating of ANIK stock?
ANIK has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the PE ratio for ANIK stock?
ANIKA THERAPEUTICS INC (ANIK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.28).
Should I buy ANIK stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ANIK.
How many employees does ANIKA THERAPEUTICS INC have?
ANIKA THERAPEUTICS INC (ANIK) currently has 288 employees.